Flora Growth Forms Flora Pharma Division, Launches Global Clinical Trials

CANNANNEW REPORT

Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. Flora Pharma’s objective is to create and leverage a proprietary drug development platform in collaboration with an artificial intelligence and machine learning group to identify new bioactive compounds within the cannabis plant that interact with certain gene targets responsible for specific disease states and conditions. Through collaborative efforts with top scientists in their respective fields, Flora intends to work with government regulators, as well as academic institutions to initiate academic studies in order to reduce costs and efficiently move through drug discovery, development, and commercialization activities and will work to create the standard for drug development/discovery for cannabinoid medicine. Flora will conduct thorough due diligence and honor the traditional FDA and NHS route in scientific processes to ensure consistency, quality, and delivery of cannabinoids for specific disease conditions, backed by data, with an initial focus on fibromyalgia, brain health, pain, and related research. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has signed an agreement to begin scientific clinical trials globally. The focus of this study will be on the use of cannabinoids in patients suffering from Fibromyalgia or chronic pain, with the primary research sites located in the United States and the United Kingdom. Flora Pharma expects to fast track traditional FDA and NHS timelines by running phase trials in parallel (in vitro, in vivo, pilot in human, safety/efficacy, etc.). The Human Pilot Study will initiate in the UK in coordination with an internationally recognized clinical research group based at the University of Manchester, while parallel molecular and pharmacokinetic studies will be…

Excerpt only …
READ MORE BELOW
Source : Flora Growth Forms Flora Pharma Division, Launches Global Clinical Trials

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.